Breaking News Bar

Business News and Information

FDA approves local biotech's first rare-cancer drug

The FDA has approved the drug Tazverik to treat metastatic or locally advanced epitheliod sarcoma, a rare and aggressive form of soft tissue cancer.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear